Evidence map›Paper›PMID 32295122›Full record

ArticleNutrients2020

Extra-Virgin Olive Oil from Apulian Cultivars and Intestinal Inflammation.

Marica Cariello, Annalisa Contursi, Raffaella Maria Gadaleta, Elena Piccinin, Stefania De Santis, Marilidia Piglionica, Ada Fiorenza Spaziante, Carlo Sabbà, Gaetano Villani, Antonio Moschetta

Open access · goldAbstract read
In one paragraph

Article in Nutrients, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed, 2 pooled it
7.6field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 2 syntheses or guidelines pooled it, 63 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. The Association Between a Mediterranean Diet and Symptoms of Irritable Bowel Syndrome.Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association · 2024
    Article
  19. Scd-1 deficiency promotes the differentiation of CD8Frontiers in cellular and infection microbiology · 2024
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Marica CarielloClinica Medica Cesare Frugoni, Department of Interdisciplinary Medicine, University of Bari "Aldo Moro", 70124 Bari, Italy.
Annalisa ContursiDepartment of Neuroscience, Imaging, and Clinical Sciences and Center for Research on Aging and Translational Medicine, "G. d'Annunzio" University School of Medicine, 66100 Chieti, Italy.
Raffaella Maria GadaletaClinica Medica Cesare Frugoni, Department of Interdisciplinary Medicine, University of Bari "Aldo Moro", 70124 Bari, Italy.ORCID 0000-0003-4951-9543
Elena PiccininClinica Medica Cesare Frugoni, Department of Interdisciplinary Medicine, University of Bari "Aldo Moro", 70124 Bari, Italy.ORCID 0000-0002-6514-2689
Stefania De SantisDepartment of Pharmacy-Drug Science, University of Bari "Aldo Moro", 70126 Bari, Italy.ORCID 0000-0001-6877-2208
Marilidia PiglionicaClinica Medica Cesare Frugoni, Department of Interdisciplinary Medicine, University of Bari "Aldo Moro", 70124 Bari, Italy.
Ada Fiorenza SpazianteDepartment of Basic Medical Sciences, Neurosciences and Sense Organs, University of Bari "Aldo Moro", 70124 Bari, Italy.
Carlo SabbàClinica Medica Cesare Frugoni, Department of Interdisciplinary Medicine, University of Bari "Aldo Moro", 70124 Bari, Italy.
Gaetano VillaniDepartment of Basic Medical Sciences, Neurosciences and Sense Organs, University of Bari "Aldo Moro", 70124 Bari, Italy.
Antonio MoschettaClinica Medica Cesare Frugoni, Department of Interdisciplinary Medicine, University of Bari "Aldo Moro", 70124 Bari, Italy.ORCID 0000-0003-2123-6074
University of Bari Aldo Moro · ITIstituto Tumori Bari · ITUniversity of Chieti-Pescara · IT

Funding

Associazione Italiana per la Ricerca sul Cancro 23239HDHL-INTIMIC the joint Programming Initiative "A Healthy Diet for a Healthy Life" Identification of the molecular interplay between dietary fatty acids and gut microbiota in non alcoholic fatty liver disease (FATMAL)MIUR PRIN 2017 Gut-liver axis and the gut vascular barrier in homeostasis and disease" (ID. 2017J3E2W2_002)PON01_01958 PIVOLIO "Processi innovativi per la valorizzazione dell'olio extravergine di oliva nelle province di Bari e Foggia".
6 · The paper itself

Abstract

Inflammatory bowel disease (IBD) is a multifactorial intestinal disorder characterized by chronic intestinal inflammation. The etiology of IBD is still unclear, although genetic, environmental and host factors have been associated to the disease. Extra-virgin olive oil (EVO) is a central component of the Mediterranean diet and it decreases chronic inflammation by interfering with arachidonic acid and NF-κB signaling pathways. Specifically, the different components of EVO are able to confer advantages in terms of health in their site of action. For instance, oleic acid displays a protective effect in liver dysfunction and gut inflammation, whereas phenolic compounds protect colon cells against oxidative damage and improve the symptoms of chronic inflammation in IBD. Given the biological properties of EVO, we investigated whether its administration is able to confer protection in a mouse model of dextrane sodium sulfate (DSS)-induced colitis. Four EVO cultivars from the Apulian Region of Italy, namely Ogliarola (Cima di Bitonto), Coratina, Peranzana and Cima di Mola, respectively, were used. Administration of EVO resulted in reduced body weight loss in our colitis model. Furthermore, mice treated with Ogliarola, Coratina and Cima di Mola EVO displayed a reduction of rectal bleeding and IL-1β, TGFβ, IL-6 gene expression levels. Furthermore, Ogliarola, Coratina and Peranzana EVO administration ameliorated intestinal permeability and histopathological features of inflammation. Our data further validate the well-known positive effects of EVO supplementation in promoting human health and suggest the bona fide contribution of EVO in preventing onset and reducing progression of intestinal inflammation.

Indexed as

Dietary SupplementsAdministration, OralAnimalsBody WeightColitisDextran SulfateDiet, MediterraneanDisease Models, AnimalGene ExpressionInflammationInterleukin-1betaInterleukin-6Intestinal MucosaItalyMaleMice, Inbred C57BLDextran SulfateInterleukin-1betaInterleukin-6Olive OilTransforming Growth Factor betaanimal experimentationinflammatory bowel diseaseintestinal inflammationmouse modelolive oil

Identifiers

PMID32295122
PMCPMC7230776
OpenAlexW3016299945

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.